综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Business

Private equity heads for healthcare firms at 4 sites

By Cai Xiao | China Daily | Updated: 2014-04-29 09:00

Domestic private equity firm China Science and Merchants Capital Management Ltd will invest at least 30 billion yuan ($4.8 billion) in the nation's health industry within five years, its chairman said.

The funds will go into companies in industrial bases in Tianjin, Shanghai, Guangzhou and Huzhou in Zhejiang province that were set up by CSM Group and local governments.

"The supply of healthcare products and equipment in China can't satisfy the huge demand of the public, so there are many investment opportunities," said Shan Xiangshuang, chairman of CSM Group.

CSM Group and Healthcare UK have signed a memorandum of understanding to bring advanced medical technology and products from Britain to China. Healthcare UK is a joint initiative of the Department of Health, UK Trade and Investment and NHS England.

The two parties will introduce British healthcare companies to the industrial bases and innovation platforms of CSM Group. There were 11 innovation platforms to support startup enterprises in 2013, and that number will be 50 by the end of this year.

With more than 60 billion yuan under management, CSM Group has invested more than 10 billion yuan in more than 100 health-related enterprises, of which Xiangxue Pharmaceutical Co Ltd and Ringpu Bio-Pharmacy Co Ltd have been listed.

In 2009, CSM Group and China Securities Co Ltd invested 64 million yuan in Xiangxue, which went public on the ChiNext board in 2010. Ringpu received 48 million yuan from CSM Group in 2008 and went public on the ChiNext board in 2010.

Shan said that CSM Group is also investing in early-stage companies in the medical sector. For example, Micro-Tech received 4 million yuan from CSM Group when it was just starting up. Now, it's preparing to go public.

Private equity firms are seeking opportunities in China's health market. For instance, the Carlyle Group LP is setting up its fourth Asia-focused buyout fund for healthcare and consumer investments and China is its largest destination.

Warburg Pincus LLC, Fosun Group and CDH Investments were also active in the sector in 2013.

caixiao@chinadaily.com.cn

 

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
洪江市| 周至县| 原阳县| 溆浦县| 郑州市| 鄢陵县| 分宜县| 桂东县| 登封市| 广丰县| 那坡县| 镇沅| 翁牛特旗| 班戈县| 勃利县| 浠水县| 正阳县| 水富县| 仪征市| 公安县| 平阳县| 漳州市| 崇信县| 随州市| 霍邱县| 库尔勒市| 常德市| 绵阳市| 宜君县| 梁平县| 云浮市| 麟游县| 福鼎市| 涪陵区| 英山县| 新巴尔虎右旗| 汤原县| 新竹县| 湟源县| 绥江县| 丹巴县|